相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of High-Density Lipoprotein Metabolism
Kerry-Anne Rye et al.
CIRCULATION RESEARCH (2014)
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States
Meredith C. Foster et al.
AMERICAN HEART JOURNAL (2013)
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency
Sara Simonelli et al.
BIOLOGICALS (2013)
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
A. Baragetti et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Evolving importance of kidney disease: from subspecialty to global health burden
Kai-Uwe Eckardt et al.
LANCET (2013)
Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production
Hamid Moradi et al.
TRANSLATIONAL RESEARCH (2013)
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
Laura Calabresi et al.
ATHEROSCLEROSIS (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters
Zhu Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in Mice
Xavier Rousset et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Lecithin: Cholesterol Acyltransferase, High-Density Lipoproteins, and Atheroprotection in Humans
Laura Calabresi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin: cholesterol acyltransferase in end-stage renal disease (ESRD)
Madeleine V. Pahl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease
Hamid Moradi et al.
TRANSLATIONAL RESEARCH (2009)
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients
Guido Franceschini et al.
ATHEROSCLEROSIS (2007)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
ND Vaziri
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes -: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families
L Calabresi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway
M Tsujita et al.
JOURNAL OF LIPID RESEARCH (2005)
Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: A stable isotope study
K Okubo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Depletion of pre-β-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1-but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein
E Favari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I
KA Rye et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
LCAT-dependent conversion of Preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients
T Miida et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study
JC Longenecker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
L Calabresi et al.
ATHEROSCLEROSIS (2000)
分享论文
